202 Efficacy and Safety of Icotrokinra, a Novel Targeted Oral Peptide, in Adolescents With Moderate-to-Severe Plaque Psoriasis: Subgroup Analyses From the Phase 3 ICONIC-LEAD Study
Journal of Investigative Dermatology · 2025-11 · 145 (11) · e62
DOI: 10.1016/j.jid.2025.09.207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2025-11. Verfasst von Lawrence Eichenfield und 20 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Eichenfield, L., Galimberti, R., Hebert, A., Wang, W., Soung, J., Magnolo, N., Browning, J., Moore, A., Lebwohl, M., Wilsmann-Theis, D., Merola, J. F., Kokolakis, G., Mortazawi, D., Grewal, P., Miller, M., Cafone, J., Li, S., Jiang, G., Nunes, F., …, & Paller, A. (2025). 202 Efficacy and Safety of Icotrokinra, a Novel Targeted Oral Peptide, in Adolescents With Moderate-to-Severe Plaque Psoriasis: Subgroup Analyses From the Phase 3 ICONIC-LEAD Study. Journal of Investigative Dermatology, 145(11), e62. https://doi.org/10.1016/j.jid.2025.09.207
Vancouver
Eichenfield L, Galimberti R, Hebert A, Wang W, Soung J, Magnolo N, et al. 202 Efficacy and Safety of Icotrokinra, a Novel Targeted Oral Peptide, in Adolescents With Moderate-to-Severe Plaque Psoriasis: Subgroup Analyses From the Phase 3 ICONIC-LEAD Study. Journal of Investigative Dermatology. 2025;145(11):e62. doi:10.1016/j.jid.2025.09.207
BibTeX
@article{Eichenfield2025,
author = {Eichenfield, Lawrence and Galimberti, Ricardo and Hebert, Adelaide and Wang, Wenhui and Soung, Jennifer and Magnolo, Nina and Browning, John and Moore, Angela and Lebwohl, Mark and Wilsmann-Theis, Dagmar and Merola, Joseph F. and Kokolakis, Georgios and Mortazawi, Dariusch and Grewal, Parbeer and Miller, Megan and Cafone, Joseph and Li, Shu and Jiang, Gig and Nunes, Fabio and DeKlotz, Cynthia and Paller, Amy},
title = {202 Efficacy and Safety of Icotrokinra, a Novel Targeted Oral Peptide, in Adolescents With Moderate-to-Severe Plaque Psoriasis: Subgroup Analyses From the Phase 3 ICONIC-LEAD Study},
journal = {Journal of Investigative Dermatology},
year = {2025},
volume = {145},
number = {11},
pages = {e62},
doi = {10.1016/j.jid.2025.09.207}
}
EUVIMED